Neogen Corp. (NEOG)
9.80
-0.12
(-1.26%)
USD |
NASDAQ |
Jan 23, 16:00
9.80
0.00 (0.00%)
After-Hours: 20:00
Neogen Research and Development Expense (TTM): 20.47M for Nov. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Teleflex, Inc. | 176.71M |
| AbbVie, Inc. | 8.815B |
| Myriad Genetics, Inc. | 111.00M |
| Amgen, Inc. | 6.828B |
| Outlook Therapeutics, Inc. | 33.72M |